Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys

Neuropsychopharmacology

Volumn 40, Issue 9, 2015, Pages 2207-2216

  Desai, Rajeev I ^a   Bergman, Jack ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIBATIDINE; NANOPARTICLE; NICOTINE; NICOTINE VACCINE; NICOTINIC AGENT; SEL 068; UNCLASSIFIED DRUG; VARENICLINE; BERBERINE; EPIBERBERINE; IMMUNOLOGIC FACTOR; VACCINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; DRUG POTENCY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; MALE; MEDICAL SCHOOL; NONHUMAN; PRIORITY JOURNAL; SQUIRREL MONKEY; TOBACCO DEPENDENCE; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECTS; PERCEPTIVE DISCRIMINATION; TIME FACTOR;

ANALYSIS OF VARIANCE; ANIMALS; BERBERINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNIZATION; IMMUNOLOGIC FACTORS; MALE; NANOPARTICLES; NICOTINE; NICOTINIC AGONISTS; SAIMIRI; TIME FACTORS; VACCINES; VARENICLINE;

EID: 84937163321     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.64     Document Type: Article

References (24)

1. Carrera MR, Ashley JA, Hoffman TZ, Isomura S, Wirsching P, Koob GF et al (2004). Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorg Med Chem 12: 563-570.
2. Cunningham CS, Javors M, McMahon LR (2012). Pharmacologic characterization of a nicotine discriminative stimulus in rhesus monkeys. J Pharmacol Exp Ther 341: 840-849.
3. Damaj MI, Creasy KR, Grove AD, Rosecrans JA, Martin BR (1994). Pharmacological effects of epibatidine optical enantiomers. Brain Res 664: 34-40.
4. Desai RI, Bergman J (2014). Methamphetamine-like discriminative-stimulus effects of nicotinic agonists. J Pharmacol Exp Ther 348: 478-488.
5. Desai RI, Barber DJ, Terry P (2003). Dopaminergic and cholinergic involvement in the discriminative-stimulus effects of nicotine and cocaine in rats. Psychopharmacology (Berl) 167: 335-343.
6. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Malmerfelt A, Johansson AM et al (2002). Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell. Respiration 69: 247-253.
7. Fraser CC, Altreuter DH, IIyinskii P, Pittet L, LaMothe RA, Keegan M et al (2014). Generation of universal CD4 memory T cell recall peptide effective in humans and non-human primates. Vaccine 32: 2896-2903.
8. Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J (2012). Nicotine vaccines for smoking cessation. Cochrane Datebase Syst Rev 8: CD007072.
9. Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH (2011). Patterns of nicotinic receptor antagonism: nicotine discrimination studies. J Pharmacol Exp Ther 339: 194-202.
10. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith BJ (1993). Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology (Berl) 111: 259-270.
11. Kelleher RT, Morse WH (1968). Determinants of the specificity of behavioral effects of drugs. Ergebnisse Physiol 60: 1-56.
12. Kishimoto K, Altreuter D, Johnston L, Keller P, Pittet L (2012). SEL-068 A fully synthetic nanoparticle vaccine for smoking cessation and relapse prevention. SRNT 2012 Annual Meeting: Houston, TX, USA.
13. LeSage MG, Shelley D, Pravetoni M, Pentel PR (2012). Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonists. Pharmacol Biochem Behav 102: 157-162.
14. LeSage MG, Keyler DE, Hieda Y, Collins G, Burroughs D, Le C et al (2006). Effects of nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats. Psycho-pharmacology (Berl) 184: 409-416.
15. Lindblom N, de Villers SH, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2002). Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 69: 254-260.
16. Lindblom N, de Villers SH, Semenova S, Kalayanov G, Gordon S, Schilstrom B et al (2005). Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs. Naunyn Schmiedebergs Arch Pharmacol 372: 182-194.
17. Pentel PR, LeSage MG (2014). New directions in nicotine vaccine design and use. Adv Pharmacol 69: 553-580.
18. Perkins KA (2009). Discriminative stimulus effects of nicotine in humans. Handb Exp Pharmacol 192: 369-400.
19. TM) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine. J Immunol 188 (75.11).
20. Polosa R, Benowitz NL (2011). Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 32: 281-290.
21. Raupach T, Hoogsteder PH, Onnovan Schayck CP (2012). Nicotine vaccines to assist with smoking cessation: current status of research. Drugs 72: e1-e16.
22. Smith JW, Stolerman IP (2009). Recognising nicotine: the neurobiological basis of nicotine discrimination. Handb Exp Pharmacol 192: 295-333.
23. Tidey JW, Bergman J (1998). Drug discrimination in methamphe-tamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285: 1163-1174.
24. US Department of Health and Human Services (USDHHS) The Health Consequences of Smoking-50 years of Progress: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, USA, 2014.